Reithera

Reithera company information, Employees & Contact Information

Explore related pages

Related company profiles:

ReiThera Srl is a CDMO company dedicated to technology and process development and GMP manufacturing, providing support for the clinical translation of genetic vaccines and medicinal products for advanced therapies. The company has extensive expertise in developing scalable processes for viral-vector manufacturing and a consolidated experience in GMP production of Adeno-Associated Vector (AAV), Lentivirus, Adeno Viral vector (AdV), Modified Vaccinia Ankara and Herpes Simplex Vector. ReiThera's core manufacturing capacity is based in a state-of-the-art facility, which includes stirred-tank bioreactors at scales of 50L, 200L, 1000L, and 2000L, as well as fixed-bed bioreactors for cell growth in adherence. The GMP facility also comprises a filling suite and quality control laboratories. ReiThera's headquarters, R&D laboratories, and GMP facilities are located in Rome, Italy. For more information, visit www.reithera.com

Company Details

Employees
151
Founded
-
Address
Via Di Castel Romano, 100, Roma,lazio 00128,italy
Phone
3906-9977-5399
Email
In****@****era.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Specialist jobs.
HQ
Roma, Lazio
Looking for a particular Reithera employee's phone or email?

Reithera Questions

News

Phase 1 clinical trial of HIV vaccine starts in Africa to evaluate immune responses to highly networked HIV T-cell epitopes - IAVI

Phase 1 clinical trial of HIV vaccine starts in Africa to evaluate immune responses to highly networked HIV T-cell epitopes IAVI

New Products - Science | AAAS

New Products Science | AAAS

ReiThera starts study on HIV vaccine - European Biotechnology Magazine

ReiThera starts study on HIV vaccine European Biotechnology Magazine

ReiThera Srl, the Ragon Institute and IAVI announce collaboration to advance highly networked T-cell HIV vaccine candidate towards Phase 1 clinical evaluation - IAVI

ReiThera Srl, the Ragon Institute and IAVI announce collaboration to advance highly networked T-cell HIV vaccine candidate towards Phase 1 clinical evaluation IAVI

ReiThera - businessfocusmagazine.com

ReiThera businessfocusmagazine.com

ReiThera Viral Vector Production Facility Expansion, Italy - Pharmaceutical Technology

ReiThera Viral Vector Production Facility Expansion, Italy Pharmaceutical Technology

The Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and Operations - BioProcess International

The Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and Operations BioProcess International

ReiThera Partners with SillaJen to Develop & Produce the SJ-600 Series for Clinical Trials - Contract Pharma

ReiThera Partners with SillaJen to Develop & Produce the SJ-600 Series for Clinical Trials Contract Pharma

Italy ready to fund ReiThera COVID-19 vaccine project, minister says - Reuters

Italy ready to fund ReiThera COVID-19 vaccine project, minister says Reuters

ReiThera’s Covid-19 vaccine shows promise in Phase II trial - Clinical Trials Arena

ReiThera’s Covid-19 vaccine shows promise in Phase II trial Clinical Trials Arena

Industry Needs More Efficient Viral Vector Production - Genetic Engineering and Biotechnology News

Industry Needs More Efficient Viral Vector Production Genetic Engineering and Biotechnology News

Gorilla Adenoviral Vector HIV Vaccine Candidate Funded by The Gates Foundation - Vax-Before-Travel

Gorilla Adenoviral Vector HIV Vaccine Candidate Funded by The Gates Foundation Vax-Before-Travel

ReiThera opens Italy viral vector production plant - BioProcess International

ReiThera opens Italy viral vector production plant BioProcess International

ReiThera Appoints Stefano Colloca CEO - Contract Pharma

ReiThera Appoints Stefano Colloca CEO Contract Pharma

EXCLUSIVE Italy audit court rejects public funding for ReiThera COVID-19 vaccine-sources - Reuters

EXCLUSIVE Italy audit court rejects public funding for ReiThera COVID-19 vaccine-sources Reuters

The Italian centre where the Covid-19 vaccine is being developed - Domus Web

The Italian centre where the Covid-19 vaccine is being developed Domus Web

Top Reithera Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant